Want to see JP:4506 full AI Analyst Report?

Sumitomo Dainippon Pharma Co (4506) Ratios

7 Followers

Sumitomo Dainippon Pharma Co Ratios

JP:4506's free cash flow for Q2 2026 was ¥0.62. For the 2026 fiscal year, JP:4506's free cash flow was decreased by ¥ and operating cash flow was ¥0.68. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 26	Mar 25	Mar 24
Liquidity Ratios
Current Ratio	―	1.05	1.03	0.52	1.02
Quick Ratio	―	0.66	0.71	0.30	0.77
Cash Ratio	―	0.10	0.16	0.06	0.38
Solvency Ratio	―	0.09	0.25	-0.37	-0.05
Operating Cash Flow Ratio	―	0.07	0.26	-0.47	0.03
Short-Term Operating Cash Flow Coverage	―	0.36	1.88	-0.85	0.13
Net Current Asset Value	¥ ―	¥ -319.96B	¥ -232.85B	¥ -481.80B	¥ -346.10B
Leverage Ratios
Debt-to-Assets Ratio	―	0.42	0.27	0.46	0.31
Debt-to-Equity Ratio	―	1.85	0.74	2.68	0.85
Debt-to-Capital Ratio	―	0.65	0.43	0.73	0.46
Long-Term Debt-to-Capital Ratio	―	0.60	0.38	0.46	0.38
Financial Leverage Ratio	―	4.38	2.75	5.81	2.79
Debt Service Coverage Ratio	―	1.05	2.85	-0.94	-0.56
Interest Coverage Ratio	―	2.62	4.94	-82.81	-24.37
Debt to Market Cap	―	1.05	0.26	2.60	1.04
Interest Debt Per Share	―	812.51	572.32	1.07K	879.78
Net Debt to EBITDA	―	5.63	1.32	-1.39	-58.00
Profitability Margins
Gross Profit Margin	―	56.51%	56.67%	59.76%	67.79%
EBIT Margin	―	6.56%	24.39%	-101.36%	-8.06%
EBITDA Margin	―	12.97%	28.97%	-89.35%	-0.63%
Operating Profit Margin	―	5.62%	11.11%	-112.60%	-13.86%
Pretax Profit Margin	―	4.42%	22.14%	-102.72%	-8.63%
Net Profit Margin	―	5.93%	23.58%	-100.13%	-13.41%
Continuous Operations Profit Margin	―	5.93%	23.58%	-100.12%	-17.41%
Net Income Per EBT	―	134.20%	106.50%	97.48%	155.49%
EBT Per EBIT	―	78.54%	199.33%	91.23%	62.25%
Return on Assets (ROA)	―	3.18%	13.28%	-34.71%	-6.57%
Return on Equity (ROE)	―	13.95%	36.54%	-201.82%	-18.32%
Return on Capital Employed (ROCE)	―	4.47%	9.44%	-90.35%	-10.10%
Return on Invested Capital (ROIC)	―	4.06%	8.81%	-50.67%	-8.98%
Return on Tangible Assets	―	6.34%	24.68%	-61.51%	-12.50%
Earnings Yield	―	8.16%	12.96%	-195.27%	-23.15%
Efficiency Ratios
Receivables Turnover	―	5.13	3.37	3.23	5.79
Payables Turnover	―	4.50	3.46	1.87	13.35
Inventory Turnover	―	1.84	2.30	1.10	1.90
Fixed Asset Turnover	―	8.55	10.25	5.43	9.43
Asset Turnover	―	0.54	0.56	0.35	0.49
Working Capital Turnover Ratio	―	-3.42	44.62	-2.66	4.82
Cash Conversion Cycle	―	188.30	161.82	250.18	228.26
Days of Sales Outstanding	―	71.13	108.45	112.83	63.01
Days of Inventory Outstanding	―	198.27	158.74	332.63	192.59
Days of Payables Outstanding	―	81.11	105.37	195.28	27.34
Operating Cycle	―	269.40	267.19	445.46	255.60
Cash Flow Ratios
Operating Cash Flow Per Share	―	41.53	180.51	-608.85	30.05
Free Cash Flow Per Share	―	20.14	168.91	-648.45	-2.03
CapEx Per Share	―	21.39	11.60	39.59	32.07
Free Cash Flow to Operating Cash Flow	―	0.48	0.94	1.07	-0.07
Dividend Paid and CapEx Coverage Ratio	―	1.94	15.55	-13.06	0.50
Capital Expenditure Coverage Ratio	―	1.94	15.56	-15.38	0.94
Operating Cash Flow Coverage Ratio	―	0.05	0.33	-0.58	0.03
Operating Cash Flow to Sales Ratio	―	0.04	0.16	-0.77	0.02
Free Cash Flow Yield	―	2.76%	8.14%	-159.72%	-0.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	12.25	7.72	-0.51	-4.32
Price-to-Sales (P/S) Ratio	―	0.73	1.82	0.51	0.58
Price-to-Book (P/B) Ratio	―	1.71	2.82	1.03	0.79
Price-to-Free Cash Flow (P/FCF) Ratio	―	36.19	12.29	-0.63	-399.76
Price-to-Operating Cash Flow Ratio	―	17.55	11.50	-0.67	26.96
Price-to-Earnings Growth (PEG) Ratio	―	-0.11	0.02	>-0.01	0.02
Price-to-Fair Value	―	1.71	2.82	1.03	0.79
Enterprise Value Multiple	―	11.23	7.60	-1.96	-150.00
Enterprise Value	―	580.75B	997.45B	551.14B	524.70B
EV to EBITDA	―	11.23	7.60	-1.96	-150.00
EV to Sales	―	1.46	2.20	1.75	0.94
EV to Free Cash Flow	―	72.58	14.86	-2.14	-651.80
EV to Operating Cash Flow	―	35.20	13.91	-2.28	43.96
Tangible Book Value Per Share	―	-504.51	-199.11	-602.33	-332.12
Shareholders’ Equity Per Share	―	426.59	736.16	392.82	1.02K
Tax and Other Ratios
Effective Tax Rate	―	-0.34	-0.06	0.03	-1.02
Revenue Per Share	―	1.00K	1.14K	791.76	1.40K
Net Income Per Share	―	59.49	268.99	-792.79	-187.55
Tax Burden	―	1.34	1.06	0.97	1.55
Interest Burden	―	0.67	0.91	1.01	1.07
Research & Development to Revenue	―	0.13	0.10	0.36	0.24
SG&A to Revenue	―	0.40	0.36	1.37	0.50
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.70	0.67	0.77	-0.12

Currency in JPY